418 results on '"White, Michael T"'
Search Results
2. Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model
3. Just Do It: Participation in Structured Online Curricula Reliably Improves Low ABSITE Scores
4. The utility of serology for elimination surveillance of trachoma
5. Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
6. Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project
7. Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
8. Effect of out-of-village working activities on recent malaria exposure in the Peruvian Amazon using parametric g-formula
9. Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure
10. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
11. Resource allocation strategies for insecticide-treated bed nets to achieve malaria eradication
12. How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
13. When More Is Still Not Enough: A Case of Ceftazidime-Avibactam Resistance in a Burn Patient
14. Development and validation of serological markers for detecting recent Plasmodium vivax infection
15. Negative Cross Resistance Mediated by Co-Treated Bed Nets: A Potential Means of Restoring Pyrethroid-Susceptibility to Malaria Vectors
16. Modeling resource allocation strategies for insecticide-treated bed nets to achieve malaria eradication.
17. Resource allocation strategies to achieve malaria eradication
18. Quantifying the mosquito’s sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control
19. A Cautionary Tale of Etanercept Use in Patients With Toxic Epidermal Necrolysis
20. The persistence of multiple strains of avian influenza in live bird markets
21. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda
22. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure
23. Targets of complement-fixing antibodies in protective immunity against malaria in children
24. Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria
25. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
26. Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy
27. Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria
28. Vaccine approaches to malaria control and elimination: Insights from mathematical models
29. Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands
30. Plasmodium vivaxrelapse, reinfection and recrudescence estimation using genetic data
31. Identification of novelPlasmodium vivaxproteins associated with protection against clinical malaria
32. Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa
33. Dynamics of the Antibody Response to Plasmodium falciparum Infection in African Children
34. Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage
35. Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity
36. Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
37. Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax
38. Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
39. Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax
40. Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
41. Additional file 5 of Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
42. Additional file 4 of Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
43. Additional file 2 of Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
44. Additional file 3 of Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
45. Additional file 1 of Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment
46. Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria.
47. Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation
48. Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines
49. Plasmodium vivax malaria serological exposure markers: assessing the degree and implications of cross-reactivity with P. knowlesi
50. Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.